Dr. Khurram Jamil is the Chief Medical Officer at Galectin Therapeutics, focusing on hepatology drug development. Described by colleagues as brilliant and dedicated, he has guided therapies through FDA approval and holds patents for treating liver disease. He earned his MD from Seton Hall University.
Beyond his clinical expertise, Khurram invests in professional growth, having completed executive education at Kellogg and NYU Stern. He holds certifications in coaching and decision-making, indicating a strong interest in leadership development and the business side of the pharmaceutical industry.
He holds a U. S. patent for a method of treating a specific subset of patients suffering from Hepatorenal Syndrome.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.